Nektar Therapeutics

NASDAQ: NKTR
$21.85
+$0.34 (+1.6%)
Closing price August 7, 2020
Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Amgen, Cerner, eBay, Gap, Nike, Nucor, Procter & Gamble, TJX and ViacomCBS.
Wednesday's top analyst upgrades, downgrades and initiations included Altria, Beyond Meat, Chevron, Chipotle Mexican Grill, Epizyme, FedEx, Home Depot, Mattel, Morgan Stanley, Oracle, Qualcomm and...
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.
Nektar Therapeutics shares made a handy gain on Monday after the firm announced updated results from its first-in-human Phase 1a study of NKTR-358 for the treatment of autoimmune and other chronic...
Tuesday's top analyst upgrades, downgrades and initiations included Apollo Global Management, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target and TJX Companies.
These are not the only losers after earnings, but these are the big movers to the downside that also have seen active trading on Friday after the first hour or so of the day.
The top analyst upgrades, downgrades and initiations on Friday included Activision Blizzard, ANGI Home Services, Azul, Baidu, CommScope, E*Trade, Kraft Heinz, Symantec and Uber Technologies.
Tuesday was a positive day for the broad U.S. markets. All of the major exchanges had another solid performance, making this the third consecutive positive trading session amid a bear market. Crude...
The top analyst upgrades, downgrades and initiations seen on Thursday included Arena Pharmaceuticals, Autodesk, Coca-Cola, General Electric, Marvell, Monster Beverages, Nabors and Procter &...
Monday was a down day for the broad U.S. markets. Each of the major exchanges started out the week on a negative note, with each seeing a loss of at least 2.0%. Crude oil continued lower yet again,...
Tuesday was a positive day for the broad U.S. markets. Although there seemed to be a lot of uncertainty leading up to this Election Day, it seems the markets are taking it in stride now that it’s...
Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination regimens in multiple cancer settings.
Monday was a mixed day for the broad U.S. markets. While all three major indices started out on a positive note, only two of the three finished there. Crude oil started out the week with a bang...